Loading...
|
Please use this identifier to cite or link to this item:
https://ir.cnu.edu.tw/handle/310902800/21562
|
Title: | Downregulation of HER2/neu receptor by solamargine enhances anticancer drug-mediated cytotoxicity in breast cancer cells with high-expressing HER2/neu |
Authors: | Shiu, L. Y. Liang, C. H. Huang, Y. S. Sheu, H. M. Kuo, K. W. |
Contributors: | 化粧品應用與管理系 |
Keywords: | Solamargine HER2/neu Topoisomerase II Methotrexate 5-Fluorouracil Cisplatin |
Date: | 2008-01 |
Issue Date: | 2009-07-20 11:08:22 (UTC+8) |
Publisher: | Springer |
Abstract: | Overexpression of HER2/neu is associated with drug resistance and poor outcome in breast cancer. Solamargine (SM), a glycoalkaloid purified from the herb Solanum incanum, exhibits HER2/neu gene modulation of HER2/neu high-expressing human breast cancer cell line ZR-75-1. SM downregulation of HER2/neu gene expression was determined by RT-PCR and Southern hybridization. Additionally, the membrane-bound HER2/neu receptor in highly HER2/neu-expressing breast cancer cells was determined by radioimmunoassay, immunocytochemistry, fluorescent immunocytochemistry, and flow cytometry. SM significantly decreased the number of HER2/neu receptors on the cell membrane. Methotrexate (MTX), 5-florouracil (5-Fu), and cisplatin (CDDP) are commonly used for breast carcinoma treatment in clinics; however, patients with HER2/neu overexpression exhibit resistance to these anticancer drugs. Notably, combination of MTX, 5-Fu, and CDDP with SM individually increased the susceptibility of breast cancer cells to these chemotherapeutic agents. Experimental results indicated that downregulation of HER2/neu by SM might be an effective strategy for enhancing drug susceptibility of breast cancer cells expressing high levels of HER2/neu. |
Relation: | Cell biology and toxicology 24(1):p.1-10 |
Appears in Collections: | [Dept. of Cosmetic Science and institute of cosmetic science] Periodical Articles
|
All items in CNU IR are protected by copyright, with all rights reserved.
|